0001213900-22-074030.txt : 20221121
0001213900-22-074030.hdr.sgml : 20221121
20221121085118
ACCESSION NUMBER: 0001213900-22-074030
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221118
FILED AS OF DATE: 20221121
DATE AS OF CHANGE: 20221121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jermasek Douglas
CENTRAL INDEX KEY: 0001955273
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40582
FILM NUMBER: 221403615
MAIL ADDRESS:
STREET 1: 4300 EL CAMINO REAL
STREET 2: SUITE 210
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001766140
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813638692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4300 EL CAMINO REAL, SUITE 210
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
BUSINESS PHONE: 650-384-0642
MAIL ADDRESS:
STREET 1: 4300 EL CAMINO REAL, SUITE 210
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
3
1
ownership.xml
OWNERSHIP DOCUMENT
X0206
3
2022-11-18
0
0001766140
Unicycive Therapeutics, Inc.
UNCY
0001955273
Jermasek Douglas
4300 EL CAMINO REAL, SUITE 210
LOS ALTOS
CA
94022
0
0
0
1
EVP of Corporate Strategy
Common Stock
70400
D
Stock Options
2.56
2031-10-20
Common Stock
100000
D
25,000 options vested on October 20, 2022 and the remainder vest over 36 months after the initial vesting.
/s/ Douglas Jermasek
2022-11-21